Human papillomavirus associated oropharyngeal cancer now the most common mucosal head and neck cancer in Queensland

Abstract

AbstractIntroductionThe profile and outcomes of head and neck cancer throughout Australia has changed over the past decade. The aim of this study was to perform a population‐based analysis of incidence, demographics, stage, treatments and outcomes of patients diagnosed with oropharyngeal squamous cell carcinoma (OPSCC), with a particular focus on HPV‐associated disease.MethodsThis was a retrospective analysis of prospectively collected data within the Queensland Oncology Repository (QOR) and analysed by the Queensland Cancer Control Analysis Team. The cohort included patients diagnosed in Queensland between 1 January 2015 and 31 December 2019. Outcome measures included incidence of new OPSCC cases, age‐standardised rates (ASR) (3‐year average), demographics, p16 status, stage (8th Edition American Joint Commission on Cancer), treatments, and 2‐ and 5‐year overall survival.ResultsThere were 1527 newly diagnosed OPSCC, representing 96% (1527/1584) of all oropharyngeal cancers. It was the most common head and neck cancer diagnosed, with oral cavity cancer being the second most common (n = 1171). Seventy‐seven percent were p16 positive (1170/1527), of which 87% (1019/1170) were male. The median age was 61 years and 49% (568/1170) presented with Stage I disease. The ASR was 6.3/100,000, representing a 144% incidence increase since 1982 (2.6/100,000). Radiotherapy was utilised in 91% of p16+ cases with 2‐ and 5‐ year overall survival of 89% and 79%, respectively.ConclusionOPSCC is now the most common mucosal head and neck cancer diagnosed in Queensland, having surpassed oral cavity cancer. The majority are HPV‐associated (p16+), presenting with early‐stage disease with a favourable prognosis.